Encouraging results have recently emerged regarding a new vaccine which suggests that with continued development the elimination of cervical cancer could be on the cards. The new vaccine targets the human papillomavirus...
Initial vaccinations for HPV for women aged younger than 14 years significantly reduced the incidence of condylomata acuminata, according to study results. However, out-of-pocket vaccination costs influenced vaccine...
A new survey finds even though vaccines for certain teenage illnesses are available and are found to be safe, many parents aren’t having their teens inoculated. The question is why? Researchers looked at parent...
Cervical cancer is one of the most preventable of all cancers. Screening can detect cervical cell changes before they become cancerous lesions and treatment has excellent survival outcomes. The commercial launch of a...
To meet demand from developing countries, the GAVI Alliance will take its first steps towards the introduction of human papillomavirus (HPV) and rubella vaccines๐ Premium Content - For FreeUnlock this content by...
For many vaccines, it’s easy to see a quick impact but for other vaccines that target slower-moving ailments, it can take years or even decades until a population reaps the benefits.๐ Premium Content - For...
Several leading drugmakers are cutting their prices on potentially life-saving vaccines for people in developing countries in an effort to sustain supplies via the GAVI international vaccine alliance.๐ Premium Content ...
Health Canada has approved the use of the human papilloma virus vaccine for women aged 27 to 45 to prevent cervical cancer and other diseases,๐ Premium Content - For FreeUnlock this content by becoming a Global Health...